search
Program:
Welcome and Introduction Dr. Ke En Oh (Ireland)
Case Introduction - Dr. Kunpeng Zhang (China)
Surgical Procedure by Phases: Bronchoplasty in Right Upper Lobectomy after neoadjuvant targeted therapy - Performed by Dr. Chang Chen (China)
Discussion and closing remarks - Faculty moderated by Dr. Valerie Rusch (USA)
Clinical History:
Preoperative Examinations:
EBUS：pathologically confirmed #7 nodal metastasis
PET-CT: no distant metastasis
cT3N2M0
Diagnosis and clinical strategy:
cT2N1M0
Almonertinib for 10 months
2nd PET-CT:
Clinically down-staged with negative mediastinal LNs
Post-operation: continue Almonertinib as adjuvant therapy
Pathology:
pT1N2M0, IIIA
Adenocarcinoma, EGFR 19 del
Post-op LNs: stations 7(2/2), 9(3/4), 10R(1/4), 2R(0/3), 3A(0/2), 4R(0/1), 11(0/4), 13(0/5)
Before neo-adjuvant therapy
Bronchoscope
After neo-adjuvant therapy
Shanghai Pulmonary Hospital is a modern tertiary specialized teaching hospital, integrating medical, teaching and research functions.
The Hospital has 11 clinical departments and 11 medical and technical departments, covering three national key clinical specialties in thoracic surgery, respiratory medicine, occupational disease and several municipal and university-level scientific research platforms.
Through exploration and research in the field of pulmonary treatment, the strength of thoracic surgery in Shanghai Pulmonary Hospital is among the most advanced in China.
The scope of thoracic surgery is extensive, with specialties covering seven sub-disciplines.
The Department of Thoracic Surgery of Shanghai Pulmonary Hospital, affiliated with Tongji University, has pioneered many advanced technologies in thoracic surgery and created a professional brand with pulmonary characteristics. It ranks second nationally in the ranking of “the best specialty reputation of Chinese hospitals” and in “the quantum ranking of Chinese hospitals in thoracic surgery”. It is the largest minimally invasive training base for thoracic surgery of international renown.
With the application of lumpectomy technology, the Thoracic Surgery Department of Shanghai Pulmonary Hospital has now become the world's largest thoracic surgery center counted by the number of cases, and the first in the world by the number of cases in minimally invasive surgeries.
